肝门部胆管癌外科治疗进展和争议
Chinese Journal of Hepatic Surgery (Electronic Edition)(2021)
Abstract
胆管癌(cholangiocarcinoma,CCA)是起源于胆管上皮细胞相对少见的恶性肿瘤,仅占胃肠道恶性肿瘤的3%[1],根据其解剖位置,将CCA分为肝内胆管癌(intrahepatic cholangiocarcinoma, iCCA)、肝门部胆管癌(perihilar cholangiocarcinoma, pCCA)和远端胆管癌(distal cholangiocarcinoma, dCCA),其中pCCA是最常见的类型,占胆道肿瘤的60%~70%.大多数无外科手术机会的进展期pCCA患者预后极差,中位生存期不足12个月 [2].
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined